In 1941, President Franklin Roosevelt warned Americans to "beware of that small group of selfish men who would clip the wings of the American eagle in order to feather their own nests."It was a warning that reflected what he saw playing out across the Atlantic: The fascists of Europe disempowering their people and corrupting their national institutions in order to enrich and empower themselves.Nearly a century after the rise of Hitler, Mussolini, and Franco, Donald Trump is using their same, tried-and-true tactics to corrupt Americas institutions and silence dissent.LINDA MCMAHON BLASTS HARVARD IN SCATHING LETTER TELLING ELITE UNIVERSITY IT WILL NO LONGER GET FEDERAL GRANTSSince returning to office, he has claimed the right to evaluate universities "viewpoint diversity" demanding that private institutions subject students and faculty to government "audits" of their personal beliefs.Harvards president has rightly refused, making clear that "The University will not surrender its independence or relinquish its constitutional rights."That insistence on academic freedom has been met with swift government retaliation.Trump withheld Congressionally-approved research funding. His administration openly threatened Harvard students visas. And he directed the IRS to revoke Harvards tax-exempt status.harvaThese attacks will disrupt a major economic engine, not just for Massachusetts but for the entire country.Harvard is an unrivaled leader in lifesaving medical research. Our public investments in those breakthroughs have fueled Americas innovation economy allowing us to lead the world in bringing academic research to the marketplace.This retaliation will cost lives, erode our competitive advantage, and prompt a disastrous brain drain a self-inflicted injury on which our rivals are more than happy to capitalize.None of that matters to Trump. Obviously.Its collateral damage in his larger war to centralize power, enrich himself, and codify his ideas as fact under the law.LEGAL EXPERT BACKS TRUMP ADMIN'S CRACKDOWN ON HARVARD: 'ACCOUNTABILITY MUST BE ENFORCED'That first goal centralizing power is nothing new for Trump. He has long sought to expand his power at the expense of our political institutions: attacking the legitimacy of our elections and politicizing our courts.The second self-enrichment has defined his first 100 days in office. Whether hes hawking cars at the White House, selling scammy crypto coins, or openly manipulating the stock market, he is enriching himself, his family, and his wealthy donors. All this while the American people and small businesses face skyrocketing costs due to Trumps tariffs.But the third goal using the governments authority to enforce his version of the truth. Thats what these attacks on Harvard are about. Thats what should scare any American who believes in objective truth, freedom of speech, and the rule of law.Trump and his allies dont just want to reshape our political system. They dont just want to pocket some cash and call it a day. They want to corrupt and seize control of our institutions in order to dictate how Americans learn, what we read, and how we think.Look at how Trump has altered American society since January.If universities want to remain tax-exempt, they need to serve as academic arms of the ruling political party.CLICK HERE FOR MORE FOX NEWS OPINIONIf a news network wants to keep its broadcast license, it needs to report stories the way the government wants them reported.If museums, libraries, and theaters want to stay open, they need to toss out material that may offend the White House.If law firms want to represent clients with business before the federal government, they need to bribe the president.If college students want to avoid being disappeared to foreign prisons, they need to keep their political views to themselves.These actions will not stop at the gates of elite institutions. Your personal freedom of speech and liberty of thought are just as much of a threat to Trumps power and he knows it.We cant treat this rising authoritarianism as a personal quirk or just another feature of our politics. Our republic the very idea that we should live in a democracy is facing a grave threat.For the vast majority of Americans who believe our national identity is inextricably tied to government of the people, this moment must serve as a call to unprecedented action.We all have a role to play in defending freedom. Because being an American means suffering no kings.

Harrison Burton is on his second NASCAR circuit in as many years after being let go by Wood Racing last year in the Cup series.He's now, in his own words, improved his stock in the Xfinity Series with six top-10s, including in each of his last three races (he had just two all of last year).But with the Indy 500 coming up, Burton admits that it'd be nice to get behind the wheel in that race.CLICK HERE FOR MORE SPORTS COVERAGE ON FOXNEWS.COM"I like to race anything," Burton told Fox News Digital in a recent interview.Burton has had success at Indianapolis Motor Speedway. In his very first race there in 2022, he finished third.But Burton's love for "motorsports in general" alone has him at least somewhat interested in running the Indy 500."I watch F1 every weekend that I can, IndyCar as much as I can, rally cross, Formula E, motorcross, everything. I love it. For sure, if that opportunity came," he said."My true passion is NASCAR, and I would never want to leave the NASCAR space. Getting to drive in Indy in a Cup car was one of the coolest things Ive ever done in my career. Definitely see the prestige and allure of the Indy 500, and meeting guys who have run in it, talking about what it means to those guys, its really cool."FOX SUPER 6 NASCAR CONTEST: BOB POCKRASS' ADVENTHEALTH 400 PICKS, PREDICTIONSFor the time being, Burton will have to wait until July 26 until he steps foot at Indianapolis, a track he has in his top-three, along with Daytona and Darlington."You go to Indy, and you are hauling down the straightaway. Youre staring at a wall the whole time, its a 90-degree turn, and youre like, "OK, I see exactly where Im going to hit if I dont make this corner," Burton said. "Its so fun. Its always cool to go to a place like that, just the history and the stories from there. It makes it more special when you can have a good day."Talladega was on the outside looking in, but "the atmosphere is unmatched."Burton will be back on the track on May 24, one day before the Indy 500, at the BetMGM 300 in Charlotte.Follow Fox News Digitalssports coverage on X,and subscribe tothe Fox News Sports Huddle newsletter.

President Donald Trump criticized former President Joe Biden's administration on Monday for allowing "lawlessness to permeate our country" while announcing Peace Officers Memorial Day and police week.Trump proclaimed Thursday as Peace Officers Memorial Day, continuing a 63-year tradition of honoring fallen officers on May 15. He also declared this week as National Police Week, beginning this past Sunday and going through Saturday."This week and always, we honor the courageous men and women serving in law enforcement and memorialize those who sacrificed their lives defending the thin blue line," he wrote in the proclamation.In the presidential action, Trump also called out the Biden administration for its "reckless, soft-on-crime policies," which he said made it harder for police officers to do their jobs.CELEBRATE LAW ENFORCEMENT DURING NATIONAL POLICE WEEK"A nation in chaos ceases to be a citadel of liberty. Tragically, the previous administration allowed lawlessness to permeate our country, making it harder for our law enforcement officers to do their jobs," the president wrote in the order. "Their reckless, soft-on-crime policies emboldened criminals and thugs; wreaked havoc on the sanctity of our homes, businesses, and public spaces; instilled fear; and jeopardized public trust."Trump continued by saying he is fulfilling the promises that he campaigned on to make America safe again, including taking authority at the border and "restoring the rule of law in communities nationwide."He also said that under his administration, all available resources will be utilized to ensure that officers will be equipped and trained to be the best they can be, qualified officers will be retained and recruiting will focus "on the basis of meritocracy."NATIONAL POLICE WEEK IS AN OPPORTUNITY TO SHOW COPS WE HAVE THEIR BACKSTrump also called on Congress to codify his executive order mandating the death penalty for those who murder a police officer and to pass a bill enhancing protections for police officers."I stand in steadfast solidarity with those who defend our freedoms and the families who love and support them," Trump said. "We pray for those who grieve the fallen and pledge that their lives, legacies, and sacrifices will forever be remembered by our grateful Nation."Governors have been asked to direct that the American flag be flown at half-staff on Thursday, and Trump has called on all Americans to observe National Police Week with "appropriate ceremonies and activities."

On the heels of President Donald Trumps Monday announcement of an executive order that will slash prescription drug prices in the U.S., the spotlight is on current costs and how much Americans could save.The presidents order calls for "most favored nations drug pricing" which means "the lowest price paid for a drug in other developed countries, that is the price that Americans will pay," he said."Some prescription drug and pharmaceutical prices will be reduced almost immediately by 50 to 80 to 90%," Trump said.PRESIDENT TRUMP TAKES ON 'BIG PHARMA' BY SIGNING EXECUTIVE ORDER TO LOWER DRUG PRICESKaty Dubinsky, a New York pharmacist and founder and CEO of Vitalize, applauded the move to reduce prescription prices, noting that Trumps order tackles a long-standing problem."But this will not be simple to accomplish," she told Fox News Digital."The executive order doesn't reduce costs immediately," she said. "It directs government agencies to start drafting the rules, which may take months."Here are the five most expensive prescription drugs in the U.S. by price followed by five by volume.Dubinsky detailed some of the most expensive prescription drugs in the country today and what conditions they treat.1. Lenmeldy (atidarsagene autotemcel) by Orchard Therapeutics $4.25 millionThis medication is used to treat metachromatic leukodystrophy (MLD), a rare genetic disorder that damages the nervous system, Dubinsky said."It is given once and is supposed to stop or slow down the disease in young kids," she noted.TOP 10 'ALLERGY CAPITALS' OF THE US, PLUS 4 TIPS TO MANAGE SYMPTOMS2. Hemgenix (etranacogene dezaparvovec-drlb) by CSL Behring $3.5 millionThis medication is prescribed for people with hemophilia B, a bleeding disorder."This one-time treatment helps the body make its own clotting factor, so patients dont need regular infusions," said Dubinsky.3. Elevidys (delandistrogene moxeparvovec-rokl) by Sarepta Therapeutics $3.2 millionThis prescription medication, intended for young boys, treats Duchenne muscular dystrophy (DMD), a condition that weakens muscles over time."It aims to slow down how fast the disease progresses," Dubinsky said.4. Skysona (elivaldogene autotemcel) by Bluebird Bio $3 million"This medication is used for cerebral adrenoleukodystrophy (CALD), a serious brain disease in boys," said Dubinsky. "This therapy tries to slow the damage before symptoms get worse."5. Zynteglo (betibeglogene autotemcel) by Bluebird Bio $2.8 millionZynteglo is for beta-thalassemia, a blood condition that usually requires regular transfusions."This gene therapy can help patients make healthy red blood cells on their own and reduce how often they need treatment," said Dubinsky.John Stanford, executive director of Incubate, a Washington-based coalition of early-stage life-science investors, shared his thoughts on the top five most expensive drugs by sales volume."Typically, when the government is focused on the most expensive drugs, they're focused on the metric based on sales volume rather than, for instance, a rare disease therapy with a high list price but smaller patient pool," he told Fox News Digital."Often, officials are focused on total drug spending by Medicare or other government programs."1. Keytruda (pembrolizumab) by Merck $25 billion revenue (2023)Keytruda is an immunotherapy medication used to treat a variety of cancers, including melanoma, non-small cell lung cancer, liver cancer and others."Keytruda has become Merck's crown jewel, helping the company expand its cancer treatment portfolio with more than 1,000 active clinical trials," Stanford told Fox News Digital.TERMINAL COLON CANCER PATIENT SAVED BY BREAKTHROUGH TREATMENT2. Eliquis (apixaban) by Bristol Myers Squibb and Pfizer $18.95 billionEliquis (apixaban) is an "anchor drug" for both BMS and Pfizer, according to Stanford.Apixaban is prescribed to prevent the formation of blood clots and to treat deep vein thrombosis and pulmonary embolism (a blood clot in the lungs).3. Ozempic (semaglutide) by Novo Nordisk $13.93 billionPrescribed for type 2 diabetes, the semaglutide medication Ozempic has become widely popular for its weight-loss effects and other health benefits."Ozempic's sales are powering Novo Nordisk's broader foray into GLP-1s for obesity, heart disease and liver conditions all areas with high development costs and uncertain scientific outcomes," Stanford told Fox News Digital."The money has gone toward scaling up production to meet demand for GLP-1s and avoid supply shortages."4. Humira (AbbVie) $14.4 billion (U.S. 2023 revenue)"Humira has been one of the highest-grossing drugs in history, generating over $200 billion during its exclusivity period," Stanford said.The injectable medication, which contains the active ingredient adalimumab, is used to treat rheumatoid arthritis and other inflammatory conditions.CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER5. Biktarvy by Gilead $11.85 billionBiktarvy is an HIV treatment that includes the three ingredients bictegravir, emtricitabine and tenofovir alafenamide."Biktarvy isn't just a leading HIV treatment it's the financial backbone for Gilead's move into cancer research," Stanford said.Dr. Jacob Glanville, CEO of Centivax, a San Francisco biotechnology company, said vaccines and most generic drugs would not likely be changed by the executive order."Most vaccines that Americans take cost less than a hundred dollars, while generic drugs are often less than a dollar a pill," he told Fox News Digital.What would be affected, Glanville predicted, are newer brand-name drugs still under IP exclusivity, antibody therapies, cellular therapies, gene therapies and personalized cancer vaccines."Some of these are excruciatingly expensive $100,000 to $500,000 for a treatment course for a patient. However, they are also often the most effective treatments for certain cancers, autoimmune disorders or rare diseases."The pharmaceutical industry might argue that lowering the prices on these medicines will result in a "dramatic reduction of investment" in creating such breakthroughs, said Glanville.The industry may also argue that these medicines eventually become generic at which point the prices drop, according to the expert.For more Health articles, visitwww.foxnews.com/health"From a patients perspective, the price of medical care in the United States is unsustainable, and extremely expensive medicine is part of that," he said. But "the insurance system and the hospital business also contribute.""If the prices of new medicines are capped, then effort should be made to reduce the cost of clinical trials and drug GMP manufacturing. Otherwise, we will lose a lot of innovation."Greg Norman of Fox News Digital contributed reporting.

On the heels of President Donald Trumps Monday announcement of an executive order that will slash prescription drug prices in the U.S., the spotlight is on current costs and how much Americans could save.The presidents order calls for "most favored nations drug pricing" which means "the lowest price paid for a drug in other developed countries, that is the price that Americans will pay," he said."Some prescription drug and pharmaceutical prices will be reduced almost immediately by 50 to 80 to 90%," Trump said.PRESIDENT TRUMP TAKES ON 'BIG PHARMA' BY SIGNING EXECUTIVE ORDER TO LOWER DRUG PRICESKaty Dubinsky, a New York pharmacist and founder and CEO of Vitalize, applauded the move to reduce prescription prices, noting that Trumps order tackles a long-standing problem."But this will not be simple to accomplish," she told Fox News Digital."The executive order doesn't reduce costs immediately," she said. "It directs government agencies to start drafting the rules, which may take months."Here are the five most expensive prescription drugs in the U.S. by price followed by five by volume.Dubinsky detailed some of the most expensive prescription drugs in the country today and what conditions they treat.1. Lenmeldy (atidarsagene autotemcel) by Orchard Therapeutics $4.25 millionThis medication is used to treat metachromatic leukodystrophy (MLD), a rare genetic disorder that damages the nervous system, Dubinsky said."It is given once and is supposed to stop or slow down the disease in young kids," she noted.TOP 10 'ALLERGY CAPITALS' OF THE US, PLUS 4 TIPS TO MANAGE SYMPTOMS2. Hemgenix (etranacogene dezaparvovec-drlb) by CSL Behring $3.5 millionThis medication is prescribed for people with hemophilia B, a bleeding disorder."This one-time treatment helps the body make its own clotting factor, so patients dont need regular infusions," said Dubinsky.3. Elevidys (delandistrogene moxeparvovec-rokl) by Sarepta Therapeutics $3.2 millionThis prescription medication, intended for young boys, treats Duchenne muscular dystrophy (DMD), a condition that weakens muscles over time."It aims to slow down how fast the disease progresses," Dubinsky said.4. Skysona (elivaldogene autotemcel) by Bluebird Bio $3 million"This medication is used for cerebral adrenoleukodystrophy (CALD), a serious brain disease in boys," said Dubinsky. "This therapy tries to slow the damage before symptoms get worse."5. Zynteglo (betibeglogene autotemcel) by Bluebird Bio $2.8 millionZynteglo is for beta-thalassemia, a blood condition that usually requires regular transfusions."This gene therapy can help patients make healthy red blood cells on their own and reduce how often they need treatment," said Dubinsky.John Stanford, executive director of Incubate, a Washington-based coalition of early-stage life-science investors, shared his thoughts on the top five most expensive drugs by sales volume."Typically, when the government is focused on the most expensive drugs, they're focused on the metric based on sales volume rather than, for instance, a rare disease therapy with a high list price but smaller patient pool," he told Fox News Digital."Often, officials are focused on total drug spending by Medicare or other government programs."1. Keytruda (pembrolizumab) by Merck $25 billion revenue (2023)Keytruda is an immunotherapy medication used to treat a variety of cancers, including melanoma, non-small cell lung cancer, liver cancer and others."Keytruda has become Merck's crown jewel, helping the company expand its cancer treatment portfolio with more than 1,000 active clinical trials," Stanford told Fox News Digital.TERMINAL COLON CANCER PATIENT SAVED BY BREAKTHROUGH TREATMENT2. Eliquis (apixaban) by Bristol Myers Squibb and Pfizer $18.95 billionEliquis (apixaban) is an "anchor drug" for both BMS and Pfizer, according to Stanford.Apixaban is prescribed to prevent the formation of blood clots and to treat deep vein thrombosis and pulmonary embolism (a blood clot in the lungs).3. Ozempic (semaglutide) by Novo Nordisk $13.93 billionPrescribed for type 2 diabetes, the semaglutide medication Ozempic has become widely popular for its weight-loss effects and other health benefits."Ozempic's sales are powering Novo Nordisk's broader foray into GLP-1s for obesity, heart disease and liver conditions all areas with high development costs and uncertain scientific outcomes," Stanford told Fox News Digital."The money has gone toward scaling up production to meet demand for GLP-1s and avoid supply shortages."4. Humira (AbbVie) $14.4 billion (U.S. 2023 revenue)"Humira has been one of the highest-grossing drugs in history, generating over $200 billion during its exclusivity period," Stanford said.The injectable medication, which contains the active ingredient adalimumab, is used to treat rheumatoid arthritis and other inflammatory conditions.CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER5. Biktarvy by Gilead $11.85 billionBiktarvy is an HIV treatment that includes the three ingredients bictegravir, emtricitabine and tenofovir alafenamide."Biktarvy isn't just a leading HIV treatment it's the financial backbone for Gilead's move into cancer research," Stanford said.Dr. Jacob Glanville, CEO of Centivax, a San Francisco biotechnology company, said vaccines and most generic drugs would not likely be changed by the executive order."Most vaccines that Americans take cost less than a hundred dollars, while generic drugs are often less than a dollar a pill," he told Fox News Digital.What would be affected, Glanville predicted, are newer brand-name drugs still under IP exclusivity, antibody therapies, cellular therapies, gene therapies and personalized cancer vaccines."Some of these are excruciatingly expensive $100,000 to $500,000 for a treatment course for a patient. However, they are also often the most effective treatments for certain cancers, autoimmune disorders or rare diseases."The pharmaceutical industry might argue that lowering the prices on these medicines will result in a "dramatic reduction of investment" in creating such breakthroughs, said Glanville.The industry may also argue that these medicines eventually become generic at which point the prices drop, according to the expert.For more Health articles, visitwww.foxnews.com/health"From a patients perspective, the price of medical care in the United States is unsustainable, and extremely expensive medicine is part of that," he said. But "the insurance system and the hospital business also contribute.""If the prices of new medicines are capped, then effort should be made to reduce the cost of clinical trials and drug GMP manufacturing. Otherwise, we will lose a lot of innovation."Greg Norman of Fox News Digital contributed reporting.

Independent Women's Forum economic policy director Patrice Onwuka on the GOP's hopes to pass the 'big, beautiful bill' and what to expect from upcoming inflation data from the Bureau of Labor Statistics.

Fox News contributor Joe Concha joins 'Fox & Friends First' to discuss the 'cowardly' move to oust Hogg as the Democrats' vice chair and Hollywood's plea to President Donald Trump for tax relief.

China, Trade Negotiations, Big Pharma

Middle East Forum chief editor Jim Hanson joins 'Fox & Friends First' to discuss the president's trip to Saudi Arabia and the possibility of a trip to Turkey for Russia-Ukraine peace talks.

Criminal defense attorney and federal litigator Vik Bajaj and Fix California senior advisor Katie Zacharia break down the confrontation in Newark, the Sean 'Diddy' Combs trial and the Menendez brothers resentencing on 'Fox News @ Night.'